Inhibrx Biosciences, Inc. (INBX) vs Maze Therapeutics, Inc. (MAZE)
Inhibrx Biosciences, Inc. and Maze Therapeutics, Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Maze Therapeutics, Inc. are of similar size ($1.5B and $1.5B). Across the 9 metrics below, Inhibrx Biosciences, Inc. leads on 5 and Maze Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | INBX | MAZE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,773.60%) | (37.35%) | (57.72%) |
| Return on assets | (75.44%) | (31.99%) | (49.22%) |
| Return on invested capital | 0.00% | (112.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack